AgeX Therapeutics Q2 EPS $(0.07), Same YoY, Sales $9.00K Down From $12.00K YoY
Portfolio Pulse from Benzinga Newsdesk
AgeX Therapeutics reported Q2 losses of $(0.07) per share, unchanged from the same period last year. The company's sales this quarter were $9.00K, a 25% decrease from $12.00K in the same period last year.
August 14, 2023 | 9:09 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
AgeX Therapeutics reported no change in EPS but a 25% decrease in sales YoY. This could potentially impact the company's stock negatively.
AgeX Therapeutics reported a decrease in sales, which is a negative indicator for the company's performance. This could lead to a decrease in investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100